Many are concerned about how GLP-1 therapy could affect testosterone, fertility, muscle preservation, and sexual health
Researchers hope to improve public education around the use of peptides
Sloop, K
121,134 GIP, another insulin secretion agonist, helps release insulin, particularly after eating, enhancing the effects of GLP-1 and thereby improving the overall therapeutic efficacy of the drug
Semaglutide GLP-1 lowers the chance of developing heart disease and some types of cancer, as well as other chronic diseases linked to obesity
For men, obesity may be associated with: Low testosterone and reduced muscle mass Fertility challenges, including lower sperm count and motility Sexual health issues, such as erectile dysfunction and decreased libido Metabolic conditions, including type 2 diabetes, insulin resistance, and hypertension Sleep apnea and cardiovascular risks, both of which impact long-term health When men lose excess weight, they often see improvements in testosterone levels
